MRVI

I cannot recall a company’s stock going up 30% after management decided to withdraw its previously shared guidance. Of course, despite the 30% pop after Q2 earnings, most shareholders likely feel like the below meme! There are, however, good reasons why the stock reacted like that. I will share

You can listen to this Deep Dive here While I usually focus on covering large-cap companies, I decided to spend some time studying Maravai LifeSciences (Ticker: MRVI) which is only $1.5 Billion market cap company. Admittedly, it caught my attention when one of my friends started tweeting about it.